Biotech Visionary Is Skeptical About AI’s Impact on Medical Innovation

💲 Paywalled: This content may require a subscription. Manage paywalled content settings on Scour.

The inventor of the groundbreaking Crispr gene-editing technology is skeptical about artificial intelligence replacing human effort in the realm of scientific discovery, adding to a growing debate over its impact on medical research and innovation.

View Post on Scour ↗

More from Bloomberg on Scour.